| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/01/2008 | US20080102133 Oral Pharmaceutical Preparation for Proton Pump Antagonists |
| 05/01/2008 | US20080102132 Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients |
| 05/01/2008 | US20080102131 oil component comprising water-insoluble bioactive substance is poly-dispersed while forming a domain in a matrix comprising water-soluble excipient based on water-soluble polymer, and sphericity of particulate not less than 0.9; powder characteristics allowing easy handling and high oral absorbability |
| 05/01/2008 | US20080102130 improved flow characteristics and reduced amounts of fine particles; compressing a pharmaceutical composition to 800 to 900 kPa hardness to produce one or more slugs, and milling the one or more slugs with an oscillating granulator to form granules |
| 05/01/2008 | US20080102129 Aerosol delivery of insulin; absorption by lung tissue; determination of glucose concentration in blood; calibrating dosage of insulin |
| 05/01/2008 | US20080102128 formed of amphiphilic polyamino acids which transport active principle(s), AP(s), in particular protein and peptide active principle(s) |
| 05/01/2008 | US20080102127 biodegradable polymer in combination with a hydrophobic lipid; Variation of the lipid and polymer types and variation in the ratio between the polymer and lipid components allows regulation of drug loading and release rate |
| 05/01/2008 | US20080102126 obtained by the reaction of aliphatic isocyanate prepolymers with polyols comprising tertiary nitrogen in water; wound contact material |
| 05/01/2008 | US20080102125 For increasing plasma concentration of insulin-like growth factor-1; oximination with polyoxyethylene glycol |
| 05/01/2008 | US20080102124 Modified Human Growth Hormone |
| 05/01/2008 | US20080102123 Self-gelling tunable drug delivery system |
| 05/01/2008 | US20080102121 exhibit a bimodal or multimodal release profile; solid oral dosage forms |
| 05/01/2008 | US20080102120 particle distribution is more homogeneous than in the prior art; D50 of said valsartan particles is 150 mu m or below and that the valsartan particles have a maximum diameter of no more than 1100 mu m |
| 05/01/2008 | US20080102119 Osmotic pump apparatus and associated methods |
| 05/01/2008 | US20080102118 osmotic pump tablets for controlled release of glipizide useful for administration once a day; for controlled delivery of said beneficial drug thereof into the gastrointestinal tract at a controlled rate |
| 05/01/2008 | US20080102117 Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose |
| 05/01/2008 | US20080102116 contains a super disintegrant or an effervescent couple including a foaming agent; core is partially covered by preformed shell coverings shaped to expose at least a part of the core for activation upon exposure to bodily fluids |
| 05/01/2008 | US20080102115 Modified coagulation factor IX polypeptides and use thereof for treatment |
| 05/01/2008 | US20080102114 Microparticles and Nanoparticles for the Transmucosal Delivery of Therapeutic and Diagnostic Agents |
| 05/01/2008 | US20080102113 capsules encapsulate a drug, such that the number of capsules needed to be ingested to cause emesis is fewer than the number of capsules needed to be ingested to cause overdose of the drug, so that if a person takes an overdose of the emetic encapsulated drug, he or she will vomit before drug absorbed |
| 05/01/2008 | US20080102112 Chlamydia vaccines |
| 05/01/2008 | US20080102111 Anticancer Composition for Oral Use Comprising Liposome Containing Phytosterols and Prevention or Treatment for Cancer Using the Liposome |
| 05/01/2008 | US20080102110 simple steps and high yield; low cost and can be used in production on large scale; spacer is a hydrophilic polymer, and the lipid is phosphatidylethanoaminecarbonyl |
| 05/01/2008 | US20080102109 Methods of enhancing solubility of agents |
| 05/01/2008 | US20080102108 Therapeutic film forming composition and treatment system therefor |
| 05/01/2008 | US20080102106 Wound Healing Composition Comprising Substances From Diptera Larvae |
| 05/01/2008 | US20080102105 having a surface with an application of lotion; sprayed as a continuous fiberised string; diapers, incontinence devices, sanitary napkins, pantiliners and micro-sanitary napkins |
| 05/01/2008 | US20080102104 formed of copolyesters of polycaprolactone or a copolyester of epsilon -caprolactone and at least one cyclic monomer selected from the group consisting of lactide, glycolide and trimethylene carbonate |
| 05/01/2008 | US20080102103 Dissolvable Film Composition |
| 05/01/2008 | US20080102102 Methods And Compositions For Decreasing Saliva Production |
| 05/01/2008 | US20080102101 Enhanced recovery following ocular surgery |
| 05/01/2008 | US20080102099 comprising: a viscoelastic solution comprising hyaluronic acid (HA); a drug selected from the group consisting of a steroid drug, quinolone, a non-steroid anti-inflammatory drug, an immunosuppressant and a drug that is compatible with the implant; and chitosan |
| 05/01/2008 | US20080102093 employing polymers, such as polypropylene comprising crystalline portions, such that the mass transport of the formulation through the shielding member is stopped or substantially impeded |
| 05/01/2008 | US20080102092 Animal extract from scallop shells; grinding, crystal structure; skin disorders |
| 05/01/2008 | US20080102085 Vaccines for treatment of Aids; protein or polynucleotide is delivered via a bombardment approach |
| 05/01/2008 | US20080102052 Aldehyde conjugated flavonoid preparations |
| 05/01/2008 | US20080102040 Inhibition of factor b, the alternative complement pathway and methods related thereto |
| 05/01/2008 | US20080102039 Foaming dosage form comprising betamethasone valerate, dimethyl isosorbide, propylene glycol, nonionic surfactant, sodium dodecyl sulfate, buffer and water; nonaerosol, alcohol free; nonirritating; topical skin application; dermatology |
| 05/01/2008 | US20080102038 Clobetasol spray |
| 05/01/2008 | US20080102037 Stable pharmaceutical budesonide preparation for producing propellant-free aerosols |
| 05/01/2008 | US20080102034 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102033 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102030 Particles for cell targeting |
| 05/01/2008 | US20080099945 Porous substances and methods for producing the same |
| 05/01/2008 | US20080099011 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 05/01/2008 | US20080099010 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 04/30/2008 | EP1916255A2 Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound |
| 04/30/2008 | EP1916002A1 Method for prevention of degradation of thermally unstable substance |
| 04/30/2008 | EP1915998A1 Prophylactic or therapeutic agent for corneal/conjunctival disease |
| 04/30/2008 | EP1915995A1 Aqueous solution preparation containing camptothecins |
| 04/30/2008 | EP1915990A1 Sustained release preparation |
| 04/30/2008 | EP1915989A1 Preparation with accurate dose-dividing function |
| 04/30/2008 | EP1915988A1 Tablet having multiple drug-containing segments |
| 04/30/2008 | EP1915987A1 Spray-freeze-drying process for the preparation of pellets comprising percolation drying |
| 04/30/2008 | EP1915986A1 Lipid growth factor formulations |
| 04/30/2008 | EP1915985A1 Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants |
| 04/30/2008 | EP1915423A2 Silylamine modified nanoparticulate carriers |
| 04/30/2008 | EP1915156A2 Method of treating parturient placental mammals in order to reduce maternal and/or utirine exhaustion |
| 04/30/2008 | EP1915153A2 Immediate release therapeutic systems for improved oral absorption of 7-[(e)-tert-butyloxyiminomethyl]camtothecin |
| 04/30/2008 | EP1915152A2 Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts |
| 04/30/2008 | EP1915139A1 Nanoparticulate and controlled release compositions comprising a cephalosporin |
| 04/30/2008 | EP1915138A2 Drug-surfactant complexes for sustained release |
| 04/30/2008 | EP1915137A1 Oral preparation with controlled release |
| 04/30/2008 | EP1915136A2 Coated tables with zero-order or near zero-order release kinetics |
| 04/30/2008 | EP1915135A2 Method for production of particles of pharmaceutical substances particles of pharmaceutical substances and the use thereof |
| 04/30/2008 | EP1915134A2 Formulations for 7-(t-butoxy)iminomethyl camptothecin |
| 04/30/2008 | EP1915133A1 Oil-in-water-type emulsion for topical application in dermatology |
| 04/30/2008 | EP1915132A1 Microparticle compositions of the topoisomerase i inhibitor 7-tert-butoxyiminomethylcamptothecin |
| 04/30/2008 | EP1915131A1 Process |
| 04/30/2008 | EP1915130A2 Liquid formulations |
| 04/30/2008 | EP1915129A2 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |
| 04/30/2008 | EP1915128A1 Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 04/30/2008 | EP1915127A1 Filtrate composition with a radiation absorber |
| 04/30/2008 | EP1915060A2 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition reference to related application |
| 04/30/2008 | EP1748764B1 An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production |
| 04/30/2008 | EP1736148A4 Medical emulsion of perfluororganic compounds and method for the production thereof |
| 04/30/2008 | EP1615936A4 Phosphates of secondary alcohols |
| 04/30/2008 | EP1586316B1 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 04/30/2008 | EP1545455B1 Controlled delivery system for bioactive substances |
| 04/30/2008 | EP1531805B1 Composition devoid of ascorbic acid comprising a cholesterol absorption inhibitor, an hmg-coa reductase inhibitor and a stabilizing agent |
| 04/30/2008 | EP1444248B1 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 04/30/2008 | EP1425381B1 Emu-based formulations for wound treatment related application information |
| 04/30/2008 | EP1212063B9 Topical azathioprine for the treatment of oral autoimmune diseases |
| 04/30/2008 | EP1196156B1 Transnasal anticonvulsive compositions |
| 04/30/2008 | EP0730657B1 Composition for the in vivo production of therapeutic products |
| 04/30/2008 | DE202007011825U1 Pharmazeutische Dosierungsformen Pharmaceutical dosage forms |
| 04/30/2008 | DE202006018188U1 Kühlfluid Cooling fluid |
| 04/30/2008 | DE112006001548T5 Ticlopidin-Zusammensetzungen mit modifizierter Freisetzung Ticlopidine compositions modified release |
| 04/30/2008 | DE102006051020A1 Use of enteric (meth)acrylate copolymers in controlled-release oral pharmaceutical dosage forms as drug matrix formers to reduce the effect of ethanol-induced release rate increase or decrease in vitro |
| 04/30/2008 | DE102006049674A1 Hautfreundliche W/O-Emulsionen Skin-friendly W / O emulsions |
| 04/30/2008 | CN201052218Y Plaster for treating skin fissure |
| 04/30/2008 | CN101171531A Ophthalmic devices for sustained delivery of active compounds |
| 04/30/2008 | CN101171030A Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 04/30/2008 | CN101171023A Particle and preparation containing the particle |
| 04/30/2008 | CN101171021A Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 04/30/2008 | CN101171006A Film coated preparation |
| 04/30/2008 | CN101171001A Solid transdermal therapeutic system comprising uv absorber |
| 04/30/2008 | CN101171000A Nanoparticulate and controlled release compositions comprising cyclosporine |
| 04/30/2008 | CN101170999A Methods and compositions for modified release of nutritional supplements |
| 04/30/2008 | CN101170998A Methods and compositions for modified release of nutritional supplements |